Annual long term liabilities:
$75.40M-$17.52M(-18.85%)Summary
- As of today (May 23, 2025), AUPH annual total long term liabilities is $75.40 million, with the most recent change of -$17.52 million (-18.85%) on December 31, 2024.
- During the last 3 years, AUPH annual long term liabilities has risen by +$51.77 million (+219.10%).
- AUPH annual long term liabilities is now -18.85% below its all-time high of $92.92 million, reached on December 31, 2023.
Performance
AUPH Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$86.25M+$10.85M(+14.39%)Summary
- As of today (May 23, 2025), AUPH quarterly total long term liabilities is $86.25 million, with the most recent change of +$10.85 million (+14.39%) on March 31, 2025.
- Over the past year, AUPH quarterly long term liabilities has increased by +$148.00 thousand (+0.17%).
- AUPH quarterly long term liabilities is now -9.16% below its all-time high of $94.95 million, reached on June 30, 2023.
Performance
AUPH quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AUPH Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.9% | +0.2% |
| 3 y3 years | +219.1% | +245.8% |
| 5 y5 years | +423.4% | +130.7% |
AUPH Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | +290.3% | -9.2% | +346.8% |
| 5 y | 5-year | -18.9% | +423.4% | -9.2% | +346.8% |
| alltime | all time | -18.9% | >+9999.0% | -9.2% | >+9999.0% |
AUPH Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $86.25M(+14.4%) |
| Dec 2024 | $75.40M(-18.9%) | $75.40M(-8.9%) |
| Sep 2024 | - | $82.75M(+0.9%) |
| Jun 2024 | - | $82.01M(-4.8%) |
| Mar 2024 | - | $86.11M(-7.3%) |
| Dec 2023 | $92.92M(+381.0%) | $92.92M(+4.1%) |
| Sep 2023 | - | $89.25M(-6.0%) |
| Jun 2023 | - | $94.95M(+391.8%) |
| Mar 2023 | - | $19.31M(-0.1%) |
| Dec 2022 | $19.32M(-18.2%) | $19.32M(-16.4%) |
| Sep 2022 | - | $23.10M(-2.7%) |
| Jun 2022 | - | $23.75M(-4.8%) |
| Mar 2022 | - | $24.94M(+5.5%) |
| Dec 2021 | $23.63M(-1.2%) | $23.63M(-3.0%) |
| Sep 2021 | - | $24.36M(-1.4%) |
| Jun 2021 | - | $24.70M(-3.9%) |
| Mar 2021 | - | $25.70M(+7.5%) |
| Dec 2020 | $23.91M(+66.0%) | $23.91M(-38.7%) |
| Sep 2020 | - | $39.02M(-0.2%) |
| Jun 2020 | - | $39.10M(+4.6%) |
| Mar 2020 | - | $37.39M(+159.5%) |
| Dec 2019 | $14.41M(-44.6%) | $14.41M(+6.0%) |
| Sep 2019 | - | $13.59M(-24.8%) |
| Jun 2019 | - | $18.07M(-3.2%) |
| Mar 2019 | - | $18.66M(-28.3%) |
| Dec 2018 | $26.03M(+63.1%) | $26.03M(+2.2%) |
| Sep 2018 | - | $25.47M(+23.6%) |
| Jun 2018 | - | $20.61M(+10.5%) |
| Mar 2018 | - | $18.64M(+16.9%) |
| Dec 2017 | $15.95M(+21.6%) | $15.95M(-37.0%) |
| Sep 2017 | - | $25.33M(-1.5%) |
| Jun 2017 | - | $25.71M(-33.6%) |
| Mar 2017 | - | $38.72M(+195.2%) |
| Dec 2016 | $13.12M(+31.3%) | $13.12M(+56.5%) |
| Sep 2016 | - | $8.38M(+24.6%) |
| Jun 2016 | - | $6.73M(-16.8%) |
| Mar 2016 | - | $8.08M(-19.1%) |
| Dec 2015 | $9.99M(-36.3%) | $9.99M(-12.7%) |
| Sep 2015 | - | $11.44M(-9.5%) |
| Jun 2015 | - | $12.65M(-29.9%) |
| Mar 2015 | - | $18.05M(+15.2%) |
| Dec 2014 | $15.67M(+312.0%) | $15.67M(+254.2%) |
| Sep 2014 | - | $4.42M(+1.2%) |
| Jun 2014 | - | $4.37M(+4.9%) |
| Mar 2014 | - | $4.17M(+9.6%) |
| Dec 2013 | $3.80M(+46.0%) | $3.80M(-8.3%) |
| Sep 2013 | - | $4.15M(+80.7%) |
| Jun 2013 | - | $2.30M(-6.7%) |
| Mar 2013 | - | $2.46M(-5.5%) |
| Dec 2012 | $2.61M(-54.9%) | $2.61M(+18.0%) |
| Sep 2012 | - | $2.21M(-0.7%) |
| Jun 2012 | - | $2.22M(-5.7%) |
| Mar 2012 | - | $2.36M(-59.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $5.78M(+123.2%) | $5.78M(-5.0%) |
| Sep 2011 | - | $6.09M(-4.6%) |
| Jun 2011 | - | $6.38M(-1.1%) |
| Mar 2011 | - | $6.45M(+149.1%) |
| Dec 2010 | $2.59M(+73.4%) | $2.59M(+74.3%) |
| Sep 2010 | - | $1.49M(+15.2%) |
| Jun 2010 | - | $1.29M(-12.3%) |
| Mar 2010 | - | $1.47M(-1.5%) |
| Dec 2009 | $1.49M(-84.5%) | $1.49M(+2.2%) |
| Sep 2009 | - | $1.46M(+49.5%) |
| Jun 2009 | - | $977.60K(-72.4%) |
| Mar 2009 | - | $3.54M(-63.4%) |
| Dec 2008 | $9.66M(+175.1%) | $9.66M(-7.3%) |
| Sep 2008 | - | $10.42M(-24.6%) |
| Jun 2008 | - | $13.82M(+314.3%) |
| Mar 2008 | - | $3.34M(-5.0%) |
| Dec 2007 | $3.51M(-0.8%) | $3.51M(-1.0%) |
| Sep 2007 | - | $3.55M(+5.6%) |
| Jun 2007 | - | $3.36M(+3.8%) |
| Mar 2007 | - | $3.23M(-8.7%) |
| Dec 2006 | $3.54M(+44.7%) | $3.54M(-13.2%) |
| Sep 2006 | - | $4.08M(-0.1%) |
| Jun 2006 | - | $4.08M(+103.7%) |
| Mar 2006 | - | $2.00M(-18.2%) |
| Dec 2005 | $2.45M(-34.0%) | $2.45M(-3.8%) |
| Sep 2005 | - | $2.54M(-13.2%) |
| Jun 2005 | - | $2.93M(-14.3%) |
| Mar 2005 | - | $3.42M(-7.8%) |
| Dec 2004 | $3.71M(+599.6%) | $3.71M(+6.7%) |
| Sep 2004 | - | $3.47M(+757.5%) |
| Jun 2004 | - | $405.10K(-11.5%) |
| Mar 2004 | - | $457.60K(-13.6%) |
| Dec 2003 | $529.80K(+311.0%) | $529.80K(+121.1%) |
| Sep 2003 | - | $239.60K(-23.0%) |
| Jun 2003 | - | $311.10K(+176.8%) |
| Mar 2003 | - | $112.40K(-12.8%) |
| Dec 2002 | $128.90K(+125.3%) | $128.90K(-18.8%) |
| Sep 2002 | - | $158.80K(-21.0%) |
| Jun 2002 | - | $201.10K(-10.4%) |
| Mar 2002 | - | $224.50K(+624.2%) |
| Dec 2001 | $57.20K(-1.4%) | - |
| Aug 2001 | - | $31.00K(-24.4%) |
| May 2001 | - | $41.00K(-18.2%) |
| Feb 2001 | - | $50.10K(-13.6%) |
| Nov 2000 | $58.00K(-14.6%) | $58.00K(-21.6%) |
| Aug 2000 | - | $74.00K(-44.6%) |
| May 2000 | - | $133.50K(-3.1%) |
| Feb 2000 | - | $137.80K(+102.9%) |
| Nov 1999 | $67.90K(+4.3%) | $67.90K(-66.2%) |
| Aug 1999 | - | $200.70K(+196.0%) |
| May 1999 | - | $67.80K(+2.3%) |
| Feb 1999 | - | $66.30K |
| Nov 1998 | $65.10K | - |
FAQ
- What is Aurinia Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual long term liabilities year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Aurinia Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of AUPH is $75.40M
What is the all time high annual long term liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total long term liabilities is $92.92M
What is Aurinia Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, AUPH annual total long term liabilities has changed by -$17.52M (-18.85%)
What is Aurinia Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AUPH is $86.25M
What is the all time high quarterly long term liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total long term liabilities is $94.95M
What is Aurinia Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AUPH quarterly total long term liabilities has changed by +$148.00K (+0.17%)